𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum elastase 1 in chronic pancreatic disease

✍ Scribed by Favero, G. ;Fabris, C. ;Plebani, M. ;Panucci, A. ;Piccoli, A. ;Perobelli, L. ;Burlina, A. ;Naccarato, R.

Publisher
Springer-Verlag
Year
1985
Tongue
English
Weight
379 KB
Volume
63
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum phospholipase A2 activity in chron
Serum phospholipase A2 activity in chronic pancreatic diseases
✍ Daniela Basso; Carlo Fabris; Maria Piera Panozzo; Tamara Meggiato; Giuseppe Del πŸ“‚ Article πŸ“… 1990 πŸ› Elsevier Science 🌐 English βš– 310 KB

This study was performed to investigate the phospholipase A2 (PLA2) serum activity in patients with chronic pancreatic disease. PLA2, elastase-1, total, and pancreatic isoamylase were evaluated in 40 control subjects, 28 patients with pancreatic cancer, 51 with chronic pancreatitis, and 36 with extr

Serum neopterin in chronic beryllium dis
Serum neopterin in chronic beryllium disease
✍ James Harris; Becki Bucher Bartelson; Elizabeth Barker; Ronald Balkissoon; Kathl πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 55 KB

We evaluated serum neopterin as a biomarker of chronic beryllium disease (CBD), for use in conjunction with the beryllium lymphocyte proliferation test (BeLPT) in workplace screening. Serum neopterin levels were determined by radioimmunoassay, and we compared levels in three groups: CBD (n 5 86), be